| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b55c349b43c3ecba4977fd52cc8f8c67 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-80 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-001106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0005 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
| filingDate |
2014-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c9f81855fe3e54fbfc61c4ae0d57067
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4f7ba6d7df6b0de98982139da473cf7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f9642e2fa899bd6fdf26744b7a8b732
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46fcf547bf36a2d89ab589cb0bce3810
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b71e1880cd1df3997270e7c167070d10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c038bc93d1b49daf8db2b483163c4c59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7dd1f21024183930d9ffa3fc6e4133f7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89338901e6525a49177627dc5001d22c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d2b8252d38d6575c44e4d42a4fe96aa |
| publicationDate |
2014-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20140100415-A |
| titleOfInvention |
Vaccine composition for transdermal administration |
| abstract |
It is an object of the present invention to provide a more effective cancer vaccine composition. (I) a HER2 / neu E75 peptide and / or a modified HER2 / neu E75 peptide; And (ii) a first cellular immunostimulatory promoter. ≪ Desc / Clms Page number 2 > |
| priorityDate |
2013-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |